HSA Product

APO-OLANZAPINE ODT ORALLY DISINTEGRATING TABLET 5MG

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

APO-OLANZAPINE ODT ORALLY DISINTEGRATING TABLET 5MG

Dosage Form

TABLET, ORALLY DISINTEGRATING

Regulatory Information

Approval Number

SIN14974P

Approval Date

March 30, 2016

Forensic Classification

Prescription Only

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

June 4, 2025

ATC Business ID

XN05AH03

Company Information

ManufacturerApotex Inc.

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Active Ingredients

Strength: 5.0MG

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy